Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial

Author:

Solaymani-Dodaran Masoud,Kalantari Saeed,Banihashemi Seyed Reza,Es-haghi AliORCID,Nofeli Mojtaba,Mohazzab Arash,Mokhberalsafa Ladan,Sadeghi Fariba,Mokaram Ali Rezae,Moradi Monireh Haji,Razaz Seyad Hossein,Taghdiri Maryam,Lotfi Mohsen,Setarehdan Seyed AminORCID,Masoumi Safdar,Ansarifar Akram,Ebrahimi Saeedeh,Esmailzadehha NedaORCID,Boluki Zahra,Khoramdad Malihe,Molaipour Leila,Rabiei Mohamad Hassan,Amiri Fahimeh Bagheri,Filsoof Sara,Bani-vaheb Behrooz,Derakhshani Maryam Raghami,Bayazidi Sheno,Golmoradizadeh Rezvan,Shahsavan Masoumeh,Safari Shiva,Ghahremanzadeh Neda,Mohseni Vahideh,Erfanpoor Saeed,Fallah Mehrabadi Mohammad Hossein

Funder

Razi Vaccine and Serum Research Institute

Publisher

Elsevier BV

Reference24 articles.

1. Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis;Huang;Eur. Rev. Med. Pharmacol. Sci.,2022

2. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis;Rahmani;Front. Public Health,2022

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2020

4. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) covid-19 vaccine;Falsey;N. Engl. J. Med.,2021

5. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N. Engl. J. Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3